Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥145,321 | ¥147,238 | ¥131,879 | ¥165,157 |
| - Cash | ¥49,576 | ¥35,015 | ¥45,471 | ¥29,252 |
| + Debt | ¥236,263 | ¥237,894 | ¥232,366 | ¥223,479 |
| Enterprise Value | ¥332,008 | ¥350,117 | ¥318,774 | ¥359,384 |
| Revenue | ¥65,327 | ¥65,149 | ¥65,857 | ¥70,333 |
| % Growth | 0.3% | -1.1% | -6.4% | – |
| Gross Profit | ¥23,531 | ¥23,675 | ¥23,985 | ¥25,830 |
| % Margin | 36% | 36.3% | 36.4% | 36.7% |
| EBITDA | ¥14,259 | ¥10,456 | ¥9,320 | ¥17,080 |
| % Margin | 21.8% | 16% | 14.2% | 24.3% |
| Net Income | ¥5,701 | ¥2,513 | ¥4,362 | ¥8,069 |
| % Margin | 8.7% | 3.9% | 6.6% | 11.5% |
| EPS Diluted | 115.81 | 51.05 | 88.61 | 163.92 |
| % Growth | 126.9% | -42.4% | -45.9% | – |
| Operating Cash Flow | ¥8,200 | ¥5,892 | ¥17,706 | -¥2,959 |
| Capital Expenditures | -¥8,423 | -¥4,380 | -¥6,827 | -¥10,341 |
| Free Cash Flow | -¥223 | ¥1,512 | ¥10,879 | -¥13,300 |